OpenAI has introduced a new subscription plan, ChatGPT Pro, priced at $200 per month. This plan offers users access to the company’s most advanced models and tools at scale. For those seeking powerful AI capabilities, ChatGPT Pro provides an enhanced experience for research, engineering, and other high-performance applications. The company emphasizes that this subscription is designed to empower professionals who rely on cutting-edge AI to boost their productivity.
Features of ChatGPT Pro
The ChatGPT Pro plan grants unlimited access to OpenAI’s most sophisticated models, including o1, o1-mini, GPT-4o, and Advanced Voice. OpenAI highlights that o1 Pro is the smartest model yet, optimized for producing highly reliable and accurate answers, particularly for complex tasks. Unlike the standard single-user plan, which provides access to basic models, ChatGPT Pro users can benefit from o1 Pro, which is specifically tailored for handling intricate machine learning tests in fields like mathematics, science, and programming.
In this pro mode, users can select o1 Pro from the model selection panel and initiate questions directly. While generating answers, the system will display a progress bar and send notifications within the app, indicating that the response is taking longer due to the increased processing requirements. This enhanced model is designed for those who need research-grade intelligence for their daily work.
Grants for Medical Researchers
Alongside the launch of the new subscription plan, OpenAI has also announced a special initiative, adds NIXsolutions. The company is offering 10 grants to medical researchers from top U.S. institutions to utilize ChatGPT Pro in their work. This move is aimed at accelerating breakthroughs in healthcare and other vital fields. By providing researchers with access to o1 Pro, OpenAI hopes to foster innovation and contribute to advances in scientific research.
We’ll keep you updated as more integrations become available, and more details emerge about how ChatGPT Pro will further transform research and development.